New Immunoglobulins Findings from Memorial Sloan-Kettering Cancer Center Reported (CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date)

MLA

“New Immunoglobulins Findings from Memorial Sloan-Kettering Cancer Center Reported (CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date).” Immunotherapy Weekly, 30 Dec. 2015, p. 21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.438515186&authtype=sso&custid=ns315887.

APA

New Immunoglobulins Findings from Memorial Sloan-Kettering Cancer Center Reported (CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date). (2015, December 30). Immunotherapy Weekly, 21.

Chicago

Immunotherapy Weekly. 2015. “New Immunoglobulins Findings from Memorial Sloan-Kettering Cancer Center Reported (CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date),” December 30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.438515186&authtype=sso&custid=ns315887.